1. Membrane microparticles: shedding new light into cancer cell communication

   • Paloma Silva de Souza
   • Roberta Soares Faccion
   • Raquel Ciuvalschi Maia

   Review – Cancer Research 19 August 2015 Pages: 1395 - 1406

   

2. Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer

   • Mei Xue
   • Wei Chen
   • Xu Li

   Review – Cancer Research 04 September 2015 Pages: 1407 - 1419

   

3. The difference in Ezrin–pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung

   • Kazunori Hata
   • Junji Yoshida
   • Genichiro Ishii

   Original Article – Cancer Research 08 April 2016 Pages: 1421 - 1430

   

4. Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497

   • Lin Liu
   • Lin Chen
   • Weidong Han

   Original Article – Cancer Research 13 April 2016 Pages: 1431 - 1439

   

5. Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study

   • Michael Lauseker
   • Roman Gerlach
   • Joerg Hasford

   Original Article – Cancer Research 16 April 2016 Pages: 1441 - 1447

   

6. Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells

   • Hui Hui
   • Xiaoxiao Zhang
   • Na Lu

   Original Article – Cancer Research 16 April 2016 Pages: 1449 - 1459

   

7. The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study

   • Debra E. Lyon
   • Ronald Cohen
   • Colleen K. Jackson-Cook

   Original Article – Cancer Research 21 April 2016 Pages: 1461 - 1474

   

8. Rapid staining and imaging of subnuclear features to differentiate between malignant and benign breast tissues at a point-of-care setting

   • Jenna L. Mueller
   • Jennifer E. Gallagher
   • Nimmi Ramanujam

   Original Article – Cancer Research 22 April 2016 Pages: 1475 - 1486

   

9. Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration

   • Yoshitaka Suda
   • Shinya Neri
   • Genichiro Ishii

   Original Article – Cancer Research 27 April 2016 Pages: 1487 - 1498

   

10. Exploring an herbal “wonder cure” for cancer: a multidisciplinary approach

    • Eran Ben-Arye
    • Jamal Mahajna
    • Noah Samuels

    Original Article - Cancer Research 07 May 2016 Pages: 1499 - 1508

    

11. Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer

    • Maria Luisa Gasparri
    • Giovanni Grandi
    • Andrea Papadia

    Review – Clinical Oncology 11 December 2015 Pages: 1509 - 1520

12. Is there evidence for a better health care for cancer patients after a second opinion? A systematic review

    • Dana Ruetters
    • Christian Keinki
    • Jutta Huebner

    Review – Clinical Oncology 21 December 2015 Pages: 1521 - 1528

    

13. Parotid melanoma of unknown primary

    • Jeffrey F. Scott
    • Cheryl L. Thompson
    • Meg R. Gerstenblith

    Original Article – Clinical Oncology 13 April 2016 Pages: 1529 - 1537

    

14. Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia

    • Qian Jiang
    • Zheng-Chen Liu
    • Robert Peter Gale

    Original Article – Clinical Oncology 16 April 2016 Pages: 1539 - 1547

    

15. Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China

    • Qian Jiang
    • Robert Peter Gale

    Original Article – Clinical Oncology 16 April 2016 Pages: 1549 - 1555

    

16. Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms

    • Kazuhiro Yoshida
    • Takeshi Nagasaka
    • Toshiyoshi Fujiwara

    Original Article – Clinical Oncology Open access 19 April 2016 Pages: 1557 - 1569

    

17. Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer

    • Jing-wei Fu
    • Ying Kong
    • Xu Sun

    Original Article – Clinical Oncology 19 April 2016 Pages: 1571 - 1579

    

18. Phase I trial of dovitinib (TKI258) in recurrent glioblastoma

    • Niklas Schäfer
    • Gerrit H. Gielen
    • Martin Glas

    Original Article – Clinical Oncology 21 April 2016 Pages: 1581 - 1589

    

19. Interstitial growth as an aggressive growth pattern in primary lung cancer

    • Shigeki Suzuki
    • Keiju Aokage
    • Genichiro Ishii

    Original Article – Clinical Oncology 25 April 2016 Pages: 1591 - 1598

    

20. Testicular seminoma clinical stage 1: treatment outcome on a routine care level

    • Klaus-Peter Dieckmann
    • Inken Dralle-Filiz
    • German Testicular Cancer Study Group

    Original Article – Clinical Oncology Open access 26 April 2016 Pages: 1599 - 1607

    

21. High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes

    • Natsuo Tomita
    • Norihito Soga
    • Takeshi Kodaira

    Original Article – Clinical Oncology 02 May 2016 Pages: 1609 - 1619

    

22. A novel genetic score model of UGT1A1 and TGFB pathway as predictor of severe irinotecan-related diarrhea in metastatic colorectal cancer patients

    • Jing Li
    • Qianqian Yu
    • Xianglin Yuan

    Original Article – Clinical Oncology 09 May 2016 Pages: 1621 - 1628

    

23. Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?

    • Toshio Kato
    • Masahiro Morise
    • Yoshinori Hasegawa

    Original Article – Clinical Oncology 11 May 2016 Pages: 1629 - 1640

    

24. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia

    • Vivien Schäfer
    • Jana Ernst
    • Thomas Ernst

    Original Article – Clinical Oncology 11 May 2016 Pages: 1641 - 1650

    

25. Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy

    • Chunwoo Lee
    • Dalsan You
    • Choung-Soo Kim

    Original Article – Clinical Oncology 19 May 2016 Pages: 1651 - 1657